Kadosh, David
- UT Health Science Center San Antonio · Microbiology & Immunology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #14,015
- Rising Star
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$775.8K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#14,015
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kadosh, David as a PI. Multi-PI records show the full award amount for context.
- 1R56AI167359-01A1R56Contact PIRegulation of Candida albicans gene expression in response to host environmental stressesUT Health Science Center San Antonio · Microbiology & Immunology (NIH department code)$582Kaward amount
- 1R21AI172207-01A1R21Contact PITranslational Regulation of Candida glabrata Azole ResistanceUT Health Science Center San Antonio · Microbiology & Immunology (NIH department code)$193.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kadosh, David as a PI.
FY2023 award administered by UT Health Science Center San Antonio (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardUT Health Science Center San Antonio
- 2010$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #9690
- 2021$5M Cumulative Funding